European Paediatric Soft Tissue Sarcoma Study Group RMS 2005 - a protocol for non metastatic rhabdomyosarcoma
Phase 3
Completed
- Conditions
- Rhabdomyosarcomatumor of striated muscle10072990
- Registration Number
- NL-OMON29994
- Lead Sponsor
- Academisch Medisch Centrum
- Brief Summary
Trial is onging in other countries
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 98
Inclusion Criteria
Patients with pathologically confirmed rhabdomyosarcoma
No evidence of metastatic disease
Age 6 months - < 21 years
Included in the High Risk Group
Exclusion Criteria
Previously treated except initial surgery
Pre-existing illness preventing treatment
Previous malignant tumor
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method <p>The primary endpoint of both randomizations is EFS.</p><br>
- Secondary Outcome Measures
Name Time Method <p>Secondary endpoints are Overall Survival, Progression Free Survival, Respons<br /><br>Rate (RR), and Toxicity.</p><br>